6-131650057-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_005021.5(ENPP3):c.185C>T(p.Ser62Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000694 in 1,613,958 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_005021.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ENPP3 | NM_005021.5 | c.185C>T | p.Ser62Leu | missense_variant | 3/25 | ENST00000357639.8 | |
ENPP3 | NR_133007.2 | n.268C>T | non_coding_transcript_exon_variant | 3/24 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ENPP3 | ENST00000357639.8 | c.185C>T | p.Ser62Leu | missense_variant | 3/25 | 1 | NM_005021.5 | P1 |
Frequencies
GnomAD3 genomes ? AF: 0.000335 AC: 51AN: 152072Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000995 AC: 25AN: 251296Hom.: 0 AF XY: 0.0000884 AC XY: 12AN XY: 135810
GnomAD4 exome AF: 0.0000417 AC: 61AN: 1461768Hom.: 1 Cov.: 31 AF XY: 0.0000303 AC XY: 22AN XY: 727182
GnomAD4 genome ? AF: 0.000335 AC: 51AN: 152190Hom.: 0 Cov.: 32 AF XY: 0.000349 AC XY: 26AN XY: 74396
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 21, 2022 | The c.185C>T (p.S62L) alteration is located in exon 3 (coding exon 3) of the ENPP3 gene. This alteration results from a C to T substitution at nucleotide position 185, causing the serine (S) at amino acid position 62 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at